Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma - Concepedia

Concepedia

Publication | Open Access

Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma

DOI Full Paper Access

104

Citations

30

References

2004

Year

Kensei Tobinai, Tomofumi Igarashi, Kuniaki Itoh, Yukio Kobayashi, Masafumi Taniwaki, Michinori Ogura, T. Kinoshita, T Hotta, Kohsuke Aikawa, Keitaro Tsushita,

Annals of Oncology

Hematological MalignancyLymphoid NeoplasiaAggressive B-cell LymphomaMedicineMalignant Blood DisorderImmunologyPharmacokinetic StudyPathologyImmune Checkpoint InhibitorRefractory PatientsImmunotherapyOncologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1